Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has become a Public Health Emergency of International Concern (PHEIC) causing mortality due to cytokine storm syndrome and multiorgan failure. Corticosteroids have shown considerable efficacy in studies conducted on COVID-19 patients but the relative efficacy and safety for its compassionate use remain unclear. This meta-analysis aimed to evaluate available evidence on the efficacy of corticosteroids in the management of COVID-19 patients at various stages of the disease. In this meta-analysis, we included seven trials, and their pooled analysis revealed COVID-19 patients in the treatment group (n=3334) was lower as compared to the control group (n=5585). The overall pooled analysis among COVID-19 patients showed corticosteroids could decrease mortality (OR = 0.587, CI = 0.36-0.95, and p-value 0.029). Corticosteroids had an insignificant effect on viral clearance. Findings suggest that corticosteroids are helpful in managing COVID-19 patients although further research is required.